Search Within
Content Type
Collections
Applications
Product Category
cr0003l200mm
Applied Filters:
Keyword:'cr0003l200mm'
Showing 1-21 of 21 results for "cr0003l200mm" within Site Content
Bioreactors
Learn more on mAB bioreactor production, and the products you need for this step.
Biorreactores
Obtenga más información sobre la producción en biorreactores mAB y los productos que necesita para este paso.
Bioreactor Process Development and Scale-Up for Transient Transfection-Based Lentivirus Manufacturing in Suspension Cell Culture
A step-by-step overview of suspension-based, transient transfection bioreactor process development and scaleup of lentivirus production.
Reproducible Scaling of a Cell Retention Filter Using the Cellicon® Cell Retention Solution
This page describes the design attributes of the Cellicon® filter assembly for cell retention and how they simplify scale-up of intensified upstream processes.
Operational and Financial Advantages of Cellicon® Cell Retention Solution in an N-1 Perfusion Process
This page describes the financial and operational advantages offered by the Cellicon® Cell Retention Device in an N-1 perfusion process at the 2,000 L scale in comparison to a cell retention device from another supplier.
Seed Train Intensification Using High Cell Density Cryopreservation
High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.
Mobius® iFlex Bioreactors for upstream processes
Mobius® iFlex Bioreactor family offers single-use bioreactors for mammalian cell culturing from development to production.
Production and Harvest Intensification
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
Seed Train Intensification
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
Intensificación de la producción y de la cosecha
Los desarrolladores biofarmacéuticos necesitan procesos eficientes y productivos en las fases iniciales que proporcionen anticuerpos monoclonales de alta calidad (AcM) y otros tipos de proteínas recombinantes. La intensificación de los procesos puede preparar sus estrategias de fabricación para el futuro
Intensificación del lote de semillas
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. La intensificación de los procesos puede preparar sus estrategias de fabricación para el futuro, reducir los costes y aumentar la
Cell Retention Technology and Specialized Cell Culture Media for Intensified Upstream Processing
How the Cellicon® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.
Accelerate development and optimization of cell culture media for upstream perfusion processes
This page describes the use of a small-scale perfusion bioreactor with integrated microfluidic flow control and sensor technologies to predict large-scale processes.
Optimizing CHO Cells for Higher Productivity
Cellvento 4CHO-X Expansion Medium enhances cell biomass for bioreactor inoculation in cell expansion stages.
Egg-based and Cell-based Influenza Vaccine Manufacturing Methods
Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.
Cost Modeling Vaccine Manufacturing: Estimate Production Costs for mRNA and other Vaccine Modalities
A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.
Adenovirus Vaccine Manufacturing Process
This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.
Developing and Manufacturing Attenuated Viral Vaccines
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
Building Regional Single-Use Supply Chains
Our global network of raw material suppliers and regional production sites for single-use technologies ensures business continuity for biopharma customers.
Virus-like Particle (VLP) Vaccine Bioprocessing and Formulation Steps
This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.
Scalability and Performance of Mobius® iFlex Bioreactors
This page summarizes several performance attributes and scalability data for Mobius® iFlex Bioreactors, single-use, stirred tank systems designed to support traditional and intensified fed-batch and perfusion cell culture applications.